Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/20/2025

Sustained Ventricular Tachycardia Definition and Management

Introduction to Sustained Ventricular Tachycardia

  • Sustained ventricular tachycardia (VT) is defined as VT that lasts greater than 30 seconds in duration and/or requires termination due to hemodynamic compromise in less than 30 seconds, according to the European Heart Journal and other sources 1, 2, 3, 4

Characteristics of Ventricular Tachycardia

  • Ventricular tachycardia is characterized by a cardiac arrhythmia of 3 or more consecutive complexes, originating in the ventricles, with a rate greater than 100 beats per minute (cycle length less than 600 ms) and QRS duration typically >120 ms without regularly occurring P:QRS association 1, 2, 3, 4

Clinical Importance of Sustained VT

  • The distinction between sustained and nonsustained VT is important for clinical management and prognostic implications, with sustained VT associated with higher mortality rates, even when hemodynamically stable 1, 2, 3, 4

Treatment Approach

  • Hemodynamically unstable patients with sustained VT require immediate synchronized cardioversion, as recommended by the European Heart Journal and other sources 5
  • Hemodynamically stable patients with sustained VT may be treated with antiarrhythmic medications, though cardioversion is still often necessary, and may require consideration for implantable cardioverter-defibrillator (ICD) therapy, particularly those with structural heart disease 6, 5

Long-term Management

  • Patients with sustained VT often require consideration for implantable cardioverter-defibrillator (ICD) therapy, particularly those with structural heart disease, as recommended by the European Heart Journal and other sources 6, 5
  • Long-term management may also include catheter ablation and/or antiarrhythmic medications, such as procainamide 10 mg/kg IV, which is recommended as first-line for monomorphic VT without severe heart failure or acute MI 5

REFERENCES

5

Management of Ventricular Tachycardia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025